Concepedia
Statistics
Publications
12
Citations
516
H-Index
11
Active since
2015
Affiliations
AbbVie (United States)(Current)
Framingham State University
Regeneron (United States)
Health Canada
Novartis (United States)
Hetal Sarvaiya is an author at AbbVie (United States) specializing in pharmacy, antibody-drug conjugates, and drug discovery.
Publications per year
2015–2025
Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity
Nathaniel Washburn, Inessa Schwab, Daniel Ortiz et al. · Proceedings of the National Academy of Sciences · 2015 · 226 citations · Full text
Pharmacy, Immunology, Pharmacology +17
ABBV-011, A Novel, Calicheamicin-Based Antibody–Drug Conjugate, Targets SEZ6 to Eradicate Small Cell Lung Cancer Tumors
Wolf R. Wiedemeyer, Julia Gavrilyuk, Alexander Schammel et al. · Molecular Cancer Therapeutics · 2022 · 57 citations · Full text
Pharmacy, Oncology, Pharmacology +17
Circulating Markers of Inflammation Persist in Children and Adults With Giant Aneurysms After Kawasaki Disease
Miroslaw Lech, Jamey Guess, Jay Duffner et al. · Circulation Genomic and Precision Medicine · 2019 · 45 citations · Full text
Life Sciences, Cardiology, Clinical Sciences +17
Uncialamycin-based antibody–drug conjugates: Unique enediyne ADCs exhibiting bystander killing effect
K. C. Nicolaou, Stephan Rigol, Emmanuel N. Pitsinos et al. · Proceedings of the National Academy of Sciences · 2021 · 42 citations · Full text
Pharmacy, Medicinal Chemistry, Oncology +17
Discovery of ABBV-154, an anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody-Drug Conjugate (iADC)
Adrian D. Hobson, Jianwen Xu, Dennie S. Welch et al. · Journal of Medicinal Chemistry · 2023 · 26 citations
Pharmacy, Immunology, Medicinal Chemistry +17
1–5 of 12